Back

Impact of coronary revascularisation in patients undergoing cardiovascular magnetic resonance for viability assessment

29 August 2025 (10:55 - 11:05)
Organised by: Logo
Congress Presentation Part of: Evolving strategies in heart failure management Multidisciplinary Interventions ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Antoine Lequipar

Hospital Lariboisiere, Paris (France)

5 More presentations in this session

Presentation thumbnail
Integrated multi-omic response to heart failure reverse remodeling with left ventricular assist device
Doctor X. Xu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Assessing impact of home-based digital cardiac rehabilitation on readmissions and patient outcomes following step-down from the acute heart failure virtual ward
Doctor D. Duvva (Liverpool, GB) Associate Professor R. Sankaranarayanan (Liverpool, GB)
Abstract Slides Video
Presentation thumbnail
Impact of empagliflozin on quality-of-life in real-world patients with heart failure: insights from the multinational Emp-Activity study
Professor A. Tomaszuk-Kazberuk (Bialystok, PL)
Abstract Slides Video
Presentation thumbnail
The antifibrotic effect of novel heart failure pharmacotherapies in myocardial samples of patients undergoing heart transplantation
Doctor D. Nagy (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
MAGGIC in the machine: unveiling the predictive value of a conventional risk score in the ultra-long LVAD phenotype. Insights from the STELLAR register.
Doctor C. Velasquez-Silva (Bad Oeynhausen, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Evolving strategies in heart failure management
Video

The Event

Event poster

ESC Congress 2025

29 August 2025 10:55 CET
You may be interested in
thumbnail
Congress Presentation
Revascularisation should be performed provided there is viability: pro
thumbnail
Congress Presentation
Impact of the LGE granularity to guide coronary revascularisation in ischaemic cardiomyopathy
thumbnail
Congress Presentation
Revascularisation should be performed provided there is viability: con

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources